On June 10, 2025, Bionano Genomics, Inc. appointed Dr. Kristiina Vuori to its Audit Committee, and on June 11, 2025, they held their Annual Meeting where stockholders elected two new directors, approved executive compensation, and ratified their accounting firm for 2025, with notable votes including approval for issuing 661,374 shares from Purchase Warrants.